Alerts will be sent to your verified email
Verify Email
DPL
|
Dipna Pharma.
|
JFL Life Sciences
|
Deccan Health Care
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
16.1 % | 12.26 % | 0.79 % |
|
5yr average Equity Multiplier
|
14.87 | 2.68 | 1.17 |
|
5yr Average Asset Turnover Ratio
|
1.35 | 0.93 | 0.47 |
|
5yr Avg Net Profit Margin
|
0.81 % | 5.75 % | 1.37 % |
|
Price to Book
|
1.22 | 1.12 | 0.39 |
|
P/E
|
48.16 | 10.51 | 41.07 |
|
5yr Avg Cash Conversion Cycle
|
-33.62 Days | 138.58 Days | 218.27 Days |
|
Inventory Days
|
62.45 Days | 96.42 Days | 372.92 Days |
|
Days Receivable
|
112.8 Days | 135.23 Days | 54.52 Days |
|
Days Payable
|
139.84 Days | 103.44 Days | 94.94 Days |
|
5yr Average Interest Coverage Ratio
|
2.01 | 4.03 | 12.96 |
|
5yr Avg ROCE
|
12.33 % | 17.72 % | 2.08 % |
|
5yr Avg Operating Profit Margin
|
2.41 % | 10.31 % | 7.39 % |
|
5 yr average Debt to Equity
|
5.84 | 0.9 | 0.02 |
|
5yr CAGR Net Profit
|
117.34 % | 50.43 % | 24.36 % |
|
5yr Average Return on Assets
|
1.21 % | 5.01 % | 0.68 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
9.98 % | 67.47 % | 18.42 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-56.58 % | 0.0 | -9.18 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Dipna Pharma.
|
JFL Life Sciences
|
Deccan Health Care
|
|
|---|---|---|---|
|
Segment Break-Up
|
Segment Break-Up
|
-
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|